ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) major shareholder Global Fund Lp Lind II sold 381,676 shares of ReWalk Robotics stock in a transaction on Monday, January 6th. The shares were sold at an average price of $3.36, for a total value of $1,282,431.36. Following the transaction, the insider now directly owns 1,049,430 shares of the company’s stock, valued at approximately $3,526,084.80. The trade was a 26.67 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
ReWalk Robotics Stock Performance
Shares of NASDAQ:LFWD opened at $1.98 on Thursday. ReWalk Robotics Ltd. has a twelve month low of $1.41 and a twelve month high of $8.89. The business has a fifty day moving average of $1.95 and a 200-day moving average of $2.90. The firm has a market cap of $17.44 million, a PE ratio of -0.80 and a beta of 2.08.
ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.08). ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. The company had revenue of $6.13 million during the quarter, compared to analyst estimates of $8.38 million. During the same period in the prior year, the business earned ($0.56) EPS. On average, analysts anticipate that ReWalk Robotics Ltd. will post -1.78 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on LFWD
Hedge Funds Weigh In On ReWalk Robotics
An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP acquired a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned 0.16% of ReWalk Robotics at the end of the most recent reporting period. Institutional investors and hedge funds own 26.76% of the company’s stock.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Further Reading
- Five stocks we like better than ReWalk Robotics
- What Are Trending Stocks? Trending Stocks Explained
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Discover 2 Under-the-Radar Aerospace Stocks Set for 2025 Growth
- 10 Best Airline Stocks to Buy
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.